Review
Published on 16 Oct 2025
PDE10A as a novel diagnostic and therapeutic target in cancer: insights and challenges
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1669157
- 182 views
Type at least 3 characters
2,001 articles
Case Report
Published on 16 Oct 2025
Case Report: Malignant peritoneal mesothelioma with TFG-ROS1 fusion responds to crizotinib
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1617457
- 162 views
Brief Research Report
Published on 16 Oct 2025
Immunohistochemical analysis of Enolase-1 sublocalization in benign and malignant breast tumors: potential implications for tumor progression and prognosis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1636394
- 184 views
Case Report
Published on 15 Oct 2025
Case Report: Trametinib in the treatment of patients with metastatic lung adenocarcinoma harboring NF1 mutation: a case series and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1481284
- 1,000 views
Original Research
Published on 14 Oct 2025
Integrated machine learning-based establishment of a prognostic model in multicenter cohorts for acute myeloid leukemia
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1649594
- 767 views
Original Research
Accepted on 10 Oct 2025
ENGINEERED MULTIFUNCTIONAL TRANSFORMING GROWTH FACTOR (TGF)-b TYPE II RECEPTOR ECTODOMAIN FUSIONS FOR ONCOLOGY APPLICATIONS
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1648779
- 133 views
Editorial
Published on 10 Oct 2025
Editorial: Renewed insight into cancer mechanism and therapy
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1710803
- 406 views
Original Research
Published on 09 Oct 2025
CLIC6’s role in cancer: from broad analysis to breast cancer validation
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1667589
- 518 views
Case Report
Accepted on 07 Oct 2025
HER2 Inhibitor-Based Combination Therapy for Recurrent and Metastatic Salivary Duct Carcinoma in an Elderly Patient: A Case Report and Literature Review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1590497
- 116 views
Review
Accepted on 07 Oct 2025
Intratumoral heterogeneity in small cell lung cancer and potential treatment strategies
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1657441
- 193 views
Original Research
Accepted on 07 Oct 2025
Combined cellular and biochemical profiling of Bruton's tyrosine kinase inhibitor nemtabrutinib reveals potential application in MAPK-driven cancers
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1667291
- 157 views
Original Research
Accepted on 07 Oct 2025
Integrating Single-cell Transcriptomics and Whole-genome CRISPR-CAS9 Screen Identifies a Cell Cluster Associated with Tumor Dependency in Triple-negative Breast Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1705923
- 174 views
Original Research
Published on 07 Oct 2025
Construction of a prognostic model for colorectal cancer liver metastasis based on single-cell transcriptomics and regulation of the MIF pathway
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1588514
- 807 views
Original Research
Published on 07 Oct 2025
Downregulation of SALL1 and its association with poor prognosis and the immune cell landscape in clear cell renal cell carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1624651
- 592 views
Review
Published on 03 Oct 2025
Potential immunogenic modulation of hypo-fractionated radiotherapy at optimal schedules and the subsequent vaccine-like effect of local irradiation - a systematic review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1546875
- 617 views
Mini Review
Published on 03 Oct 2025
The role of apelin in cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1683865
- 720 views